238 related articles for article (PubMed ID: 15005879)
1. Characterization of enzymes responsible for biotransformation of the new antileukotrienic drug quinlukast in rat liver microsomes and in primary cultures of rat hepatocytes.
Szotáková B; Skálová L; Baliharová V; Dvorscáková M; Storkánová L; Sispera L; Wsól V
J Pharm Pharmacol; 2004 Feb; 56(2):205-12. PubMed ID: 15005879
[TBL] [Abstract][Full Text] [Related]
2. Role of rat liver cytochrome P450 3A and 2D in metabolism of imrecoxib.
Xu HY; Xie ZY; Zhang P; Sun J; Chu FM; Guo ZR; Zhong DF
Acta Pharmacol Sin; 2006 Mar; 27(3):372-80. PubMed ID: 16490176
[TBL] [Abstract][Full Text] [Related]
3. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
Niwa T; Shiraga T; Mitani Y; Terakawa M; Tokuma Y; Kagayama A
Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
[TBL] [Abstract][Full Text] [Related]
4. Cytotoxicity of ginkgolic acid in HepG2 cells and primary rat hepatocytes.
Liu ZH; Zeng S
Toxicol Lett; 2009 Jun; 187(3):131-6. PubMed ID: 19429255
[TBL] [Abstract][Full Text] [Related]
5. In vitro metabolism of L-696,229, an HIV-1 reverse transcriptase inhibitor in rats and humans. Hepatic and extrahepatic metabolism and identification of enzymes involved in the hepatic metabolism.
Prueksaritanont T; Dwyer LM; Balani SK; Theoharides AD
Drug Metab Dispos; 1994; 22(2):281-8. PubMed ID: 7516854
[TBL] [Abstract][Full Text] [Related]
6. The effects of gender, age, ethnicity, and liver cirrhosis on cytochrome P450 enzyme activity in human liver microsomes and inducibility in cultured human hepatocytes.
Parkinson A; Mudra DR; Johnson C; Dwyer A; Carroll KM
Toxicol Appl Pharmacol; 2004 Sep; 199(3):193-209. PubMed ID: 15364537
[TBL] [Abstract][Full Text] [Related]
7. Characterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1).
Nicoll-Griffith DA; Chauret N; Yergey JA; Trimble LA; Favreau L; Zamboni R; Grossman SJ; Drey J; Herold E
Drug Metab Dispos; 1993; 21(5):861-7. PubMed ID: 7902249
[TBL] [Abstract][Full Text] [Related]
8. In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl) phenyl]methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. I. Role of cytochrome P450, methyltransferases, flavin monooxygenases, and esterases.
Karanam BV; Hop CE; Liu DQ; Wallace M; Dean D; Satoh H; Komuro M; Awano K; Vincent SH
Drug Metab Dispos; 2004 Sep; 32(9):1015-22. PubMed ID: 15319344
[TBL] [Abstract][Full Text] [Related]
9. Use of a benzyloxy-substituted lactone cyclooxygenase-2 inhibitor as a selective fluorescent probe for CYP3A activity in primary cultured rat and human hepatocytes.
Nicoll-Griffith DA; Chauret N; Houle R; Day SH; D'Antoni M; Silva JM
Drug Metab Dispos; 2004 Dec; 32(12):1509-15. PubMed ID: 15550722
[TBL] [Abstract][Full Text] [Related]
10. Formation of 4'-carboxyl acid metabolite of imrecoxib by rat liver microsomes.
Xu HY; Zhang P; Gong AS; Sun YM; Chu FM; Guo ZR; Zhong DF
Acta Pharmacol Sin; 2006 Apr; 27(4):506-12. PubMed ID: 16539853
[TBL] [Abstract][Full Text] [Related]
11. Temporal kinetics and concentration-response relationships for induction of CYP1A, CYP2B, and CYP3A in primary cultures of beagle dog hepatocytes.
Graham RA; Tyler LO; Krol WL; Silver IS; Webster LO; Clark P; Chen L; Banks T; LeCluyse EL
J Biochem Mol Toxicol; 2006; 20(2):69-78. PubMed ID: 16615094
[TBL] [Abstract][Full Text] [Related]
12. Studies on cytochrome P-450-mediated bioactivation of diclofenac in rats and in human hepatocytes: identification of glutathione conjugated metabolites.
Tang W; Stearns RA; Bandiera SM; Zhang Y; Raab C; Braun MP; Dean DC; Pang J; Leung KH; Doss GA; Strauss JR; Kwei GY; Rushmore TH; Chiu SH; Baillie TA
Drug Metab Dispos; 1999 Mar; 27(3):365-72. PubMed ID: 10064567
[TBL] [Abstract][Full Text] [Related]
13. Assessment of a dry extract from milk thistle (Silybum marianum) for interference with human liver cytochrome-P450 activities.
Doehmer J; Weiss G; McGregor GP; Appel K
Toxicol In Vitro; 2011 Feb; 25(1):21-7. PubMed ID: 20828605
[TBL] [Abstract][Full Text] [Related]
14. The role of different cytochrome P450 isoforms in in vitro chloroform metabolism.
Testai E; De Curtis V; Gemma S; Fabrizi L; Gervasi P; Vittozzi L
J Biochem Toxicol; 1996; 11(6):305-12. PubMed ID: 9176742
[TBL] [Abstract][Full Text] [Related]
15. In vitro biotransformation and investigation of metabolic enzymes possibly responsible for the metabolism of bisdesoxyolaquindox in the liver fractions of rats, chicken, and pigs.
Liu ZY; Chen DM; Huang LL; Tao YF; Yao M; Yuan ZH
Toxicology; 2011 Jan; 279(1-3):155-66. PubMed ID: 20955753
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and metabolism of a cysteinyl leukotriene-1 receptor antagonist from the heterocyclic chromanol series in rats: in vitro-in vivo correlation, gender-related differences, isoform identification, and comparison with metabolism in human hepatic tissue.
Kuperman AV; Kalgutkar AS; Marfat A; Chambers RJ; Liston TE
Drug Metab Dispos; 2001 Nov; 29(11):1403-9. PubMed ID: 11602515
[TBL] [Abstract][Full Text] [Related]
17. Effects of cytochrome P450 inhibitors on the biotransformation of fluorogenic substrates by adult male rat liver microsomes and cDNA-expressed rat cytochrome P450 isoforms.
Makaji E; Trambitas CS; Shen P; Holloway AC; Crankshaw DJ
Toxicol Sci; 2010 Feb; 113(2):293-304. PubMed ID: 19858067
[TBL] [Abstract][Full Text] [Related]
18. The stereoselective biotransformation of the anti-obesity drug sibutramine in rat liver microsomes and in primary cultures of rat hepatocytes.
Link M; Novotná R; Suchanová B; Skálová L; Wsól V; Szotáková B
J Pharm Pharmacol; 2005 Mar; 57(3):405-10. PubMed ID: 15807998
[TBL] [Abstract][Full Text] [Related]
19. The olivacine derivative s 16020 (9-hydroxy-5,6-dimethyl-N-[2-(dimethylamino)ethyl)-6H-pyrido(4,3-B)-carbazole-1-carboxamide) induces CYP1A and its own metabolism in human hepatocytes in primary culture.
Pichard-Garcia L; Weaver RJ; Eckett N; Scarfe G; Fabre JM; Lucas C; Maurel P
Drug Metab Dispos; 2004 Jan; 32(1):80-8. PubMed ID: 14709624
[TBL] [Abstract][Full Text] [Related]
20. Induction of CYP3A by 2,3-oxidosqualene:lanosterol cyclase inhibitors is mediated by an endogenous squalene metabolite in primary cultured rat hepatocytes.
Shenoy SD; Spencer TA; Mercer-Haines NA; Abdolalipour M; Wurster WL; Runge-Morris M; Kocarek TA
Mol Pharmacol; 2004 May; 65(5):1302-12. PubMed ID: 15102959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
